You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Adults,Nplate is indicated for treatment of thrombocytopenia in adult patients with primary immune
thrombocytopenia (ITP) who are:, non-splenectomised and have had an inadequate response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.,Paediatrics,Nplate is indicated for treatment of thrombocytopenia in paediatric patients aged 1 year and older with primary immune thrombocytopenia ITP for at least 6 months who are:, non-splenectomised and have had an insufficient response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Adults,Nplate is indicated for treatment of thrombocytopenia in adult patients with primary immune
thrombocytopenia (ITP) who are:, non-splenectomised and have had an inadequate response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.,Paediatrics,Nplate is indicated for treatment of thrombocytopenia in paediatric patients aged 1 year and older with primary immune thrombocytopenia ITP for at least 6 months who are:, non-splenectomised and have had an insufficient response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Adults,Nplate is indicated for treatment of thrombocytopenia in adult patients with primary immune
thrombocytopenia (ITP) who are:, non-splenectomised and have had an inadequate response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.,Paediatrics,Nplate is indicated for treatment of thrombocytopenia in paediatric patients aged 1 year and older with primary immune thrombocytopenia ITP for at least 6 months who are:, non-splenectomised and have had an insufficient response, or are intolerant, to corticosteroids and immunoglobulins;, splenectomised and have had an inadequate response to splenectomy.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
